Skip to main content

Cerebral Autosomal Dominant Arteriopathy with Subcortical Ischemic Strokes and Leukoencephalopathy (CADASIL)

  • Chapter
  • First Online:
Stroke Revisited: Pathophysiology of Stroke

Part of the book series: Stroke Revisited ((STROREV))

  • 1325 Accesses

Abstract

Of these inherited small vessel diseases, cerebral autosomal dominant arteriopathy with subcortical ischemic strokes and leukoencephalopathy (CADASIL) is the most frequent single-gene disorder caused by the mutations in the Notch3 gene located on chromosome 19p13. This Notch3 gene has 33 exons, but almost CADASIL mutations are clustered in exons 2–24. More than 95% of these mutations are missense mutations and most of which involve gain or loss of cysteine residue. However, despite the debates, novel mutation of R75P, not involving a cysteine residue, was reported in Asian populations, thus broadening the spectrum of CADASIL. The main symptoms include subcortical ischemic events, migraine, progressive cognitive decline, seizure, and psychiatric features. Typical diagnostic criteria of neuroimaging show severe white-matter hyperintensities usually involving anterior part of the temporal lobe and external capsules.

In contrast, previous studies suggested differences in the clinical and genetic spectrum of CADASIL between Asians and Caucasian populations. While exon 4 was the major Notch3 mutation sites in Caucasian population, exon 11 was the most common in Asian population. Although it is unclear that genetic differences might affect the phenotypes in ethnicities, Asian population shows less migraine or seizure, but more intracerebral hemorrhage. Furthermore, especially in patients with R75P mutations, the sensitivity of MRI detecting anterior temporal pole abnormalities was lower.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.

    Article  Google Scholar 

  2. Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry. 2005;76(5):739–41.

    Article  CAS  Google Scholar 

  3. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol. 2009;8(7):643–53.

    Article  Google Scholar 

  4. Kim Y, Choi EJ, Choi CG, Kim G, Choi JH, Yoo HW, et al. Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology. 2006;66(10):1511–6.

    Article  CAS  Google Scholar 

  5. Choi JC, Kang SY, Kang JH, Park JK. Intracerebral hemorrhages in CADASIL. Neurology. 2006;67(11):2042–4.

    Article  Google Scholar 

  6. Mizuno T, Muranishi M, Torugun T, Tango H, Nagakane Y, Kudeken T, et al. Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue. Intern Med (Tokyo, Japan). 2008;47(23):2067–72.

    Article  Google Scholar 

  7. Uchino M. The pathomechanism and treatment of CADASIL. Rinsho shinkeigaku = Clin Neurol. 2011;51(11):945–8.

    Article  Google Scholar 

  8. Kim Y, Lee S.-H. Novel characteristics of race-specific genetic functions in Korean CADASIL. Medicina. 2019;55:521. https://doi:10.3390/medicina55090521.

    Google Scholar 

  9. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain J Neurol. 2004;127(Pt 9):2031–8.

    Article  Google Scholar 

  10. Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke. 2004;35(7):1603–8.

    Article  Google Scholar 

  11. Dichgans M, Holtmannspotter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke. 2002;33(1):67–71.

    Article  Google Scholar 

  12. Lesnik Oberstein SA, van den Boom R, van Buchem MA, van Houwelingen HC, Bakker E, Vollebregt E, et al. Cerebral microbleeds in CADASIL. Neurology. 2001;57(6):1066–70.

    Article  CAS  Google Scholar 

  13. Rinnoci V, Nannucci S, Valenti R, Donnini I, Bianchi S, Pescini F, et al. Cerebral hemorrhages in CADASIL: report of four cases and a brief review. J Neurol Sci. 2013;330(1–2):45–51.

    Article  Google Scholar 

  14. Oh JH, Lee JS, Kang SY, Kang JH, Choi JC. Aspirin-associated intracerebral hemorrhage in a patient with CADASIL. Clin Neurol Neurosurg. 2008;110(4):384–6.

    Article  Google Scholar 

  15. Guey S, Mawet J, Herve D, Duering M, Godin O, Jouvent E, et al. Prevalence and characteristics of migraine in CADASIL. Cephalalgia. 2016;36(11):1038–47.

    Article  Google Scholar 

  16. Eikermann-Haerter K, Yuzawa I, Dilekoz E, Joutel A, Moskowitz MA, Ayata C. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol. 2011;69(2):413–8.

    Article  CAS  Google Scholar 

  17. Taillia H, Chabriat H, Kurtz A, Verin M, Levy C, Vahedi K, et al. Cognitive alterations in non-demented CADASIL patients. Cerebrovasc Dis (Basel, Switzerland). 1998;8(2):97–101.

    Article  CAS  Google Scholar 

  18. Buffon F, Porcher R, Hernandez K, Kurtz A, Pointeau S, Vahedi K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry. 2006;77(2):175–80.

    Article  CAS  Google Scholar 

  19. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet (London, England). 1995;346(8980):934–9.

    Article  CAS  Google Scholar 

  20. Stojanov D, Vojinovic S, Aracki-Trenkic A, Tasic A, Benedeto-Stojanov D, Ljubisavljevic S, et al. Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Bosn J Basic Med Sci. 2015;15(1):1–8.

    Article  CAS  Google Scholar 

  21. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, et al. Diagnostic strategies in CADASIL. Neurology. 2002;59(8):1134–8.

    Article  CAS  Google Scholar 

  22. O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56(5):628–34.

    Article  Google Scholar 

  23. Di Donato I, Bianchi S, De Stefano N, Dichgans M, Dotti MT, Duering M, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med. 2017;15(1):41.

    Article  Google Scholar 

  24. Lee YC, Liu CS, Chang MH, Lin KP, Fuh JL, Lu YC, et al. Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese. J Neurol. 2009;256(2):249–55.

    Article  CAS  Google Scholar 

  25. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet (London, England). 1997;350(9090):1511–5.

    Article  CAS  Google Scholar 

  26. Oberstein SA, Ferrari MD, Bakker E, van Gestel J, Kneppers AL, Frants RR, et al. Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL research group. Neurology. 1999;52(9):1913–5.

    Article  CAS  Google Scholar 

  27. Mykkanen K, Savontaus ML, Juvonen V, Sistonen P, Tuisku S, Tuominen S, et al. Detection of the founder effect in Finnish CADASIL families. Eur J Hum Genet. 2004;12(10):813–9.

    Article  Google Scholar 

  28. Dotti MT, Federico A, Mazzei R, Bianchi S, Scali O, Conforti FL, et al. The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry. 2005;76(5):736–8.

    Article  CAS  Google Scholar 

  29. Wollenweber FA, Hanecker P, Bayer-Karpinska A, Malik R, Bazner H, Moreton F, et al. Cysteine-sparing CADASIL mutations in NOTCH3 show proaggregatory properties in vitro. Stroke. 2015;46(3):786–92.

    Article  CAS  Google Scholar 

  30. Choi JC, Song SK, Lee JS, Kang SY, Kang JH. Diversity of stroke presentation in CADASIL: study from patients harboring the predominant NOTCH3 mutation R544C. J Stroke Cerebrovasc Dis. 2013;22(2):126–31.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kim, Y. (2020). Cerebral Autosomal Dominant Arteriopathy with Subcortical Ischemic Strokes and Leukoencephalopathy (CADASIL). In: Lee, SH. (eds) Stroke Revisited: Pathophysiology of Stroke. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1430-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1430-7_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1429-1

  • Online ISBN: 978-981-10-1430-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics